1 |
Beardow AW, Buchanan JW. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987–1991). J Am Vet Med Assoc 1993; 203: 1023–1029
PUBMED
|
2 |
Chu KM, Shieh SM, Hu OY. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing. Clin Pharmacol Ther 1995; 57: 610-621
DOI
ScienceOn
|
3 |
Haggstrom J, Hamlin RL, Hansson K. Heart rate variability in relation to severity of mitral regurgitation in Cavalier King Charles spaniels. J Small Anim Pract 1996; 37: 69–75
DOI
ScienceOn
|
4 |
Hyun C. Valvular disease. In: Textbook of Small Animal Cardiology, Seoul: Panmoon Publishing. 2005: 185–206
|
5 |
Justin D. Thomason, Tiffany K. Fallaw, Clay A. Calvert. Pimobendan: Understanding its cardiac effects in dogs with myocardial disease. Vet Med 2006: 660-667
|
6 |
Wess G. Assessment of left ventricular systolic and diastolic function in canine myxomatous mitral valve disease using myocardial tissue Doppler imaging. In: International canine valvular disease symposium, Stockholm, Sweden. 2008: 44-45
|
7 |
H ggstr m J, Boswood A, O'Grady M, J ns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kova evi A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, 'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, Difruscia R. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring oyxomatous mitral valve disease: The QUEST study. J Vet Intern Med 2008; 22: 1124-1135
DOI
ScienceOn
|
8 |
Lombard CW, Jons O, Bussadoril CM. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 2006; 42: 249-261
PUBMED
|
9 |
Fuentes VL, Corcoran B, French A, et al. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Intern Med 2002; 16: 255-261
DOI
ScienceOn
|
10 |
Kleeman R, Lebobinnee G, Bruyere D. Clinical efficacy of the novel inodilator pimobendan in dogs suffering from congestive heart failure, in Proceedings. Br Small Anim Vet Congress 1998
|
11 |
Kittleson MD, Kienle RD. Myxomatous atrioventricular valvular degeneration. In: Small Animal Cardiovascular Medicine. St Louis: Mosby. 1998: 297–318
|
12 |
Hagemeijer F. Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure. Eur Heart J 1993; 14: 551-566.
DOI
PUBMED
ScienceOn
|
13 |
Moon HS, Choi E, Hyun C. The cardiac sodium-calcium exchanger gene (NCX-1) is a potential canine cardiac biomarker of chronic mitral valvular insufficiency. J Vet Intern Med 2008; 22: 1360-1365
DOI
ScienceOn
|
14 |
Hyun C. Mitral valve prolapse in Cavalier King Charles spaniel: a review and case study. Vet Sci 2005; 6: 67-73
PUBMED
|
15 |
Serres F, Chetboul V, Tissier R, Poujol L, Gouni V, Carlos Sampedrano C, Pouchelon JL, 'Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: correlation with disease severity and prognostic value in dogs with mitral valve disease', J Vet Intern Med. 2008; 22: 566-577
DOI
ScienceOn
|
16 |
Smith PJ, French AT, Van Israel N. Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease. J Small Anim Pract 2005; 46: 121-130
DOI
ScienceOn
|
17 |
Fuentes VL. Use of pimobendan in the management of heart failure. Vet Clin North Am Small Anim Pract 2004; 34: 1145-1155
DOI
ScienceOn
|
18 |
Pouchelon JL, Jamet N, Gouni V, Tissier R, Serres F, Carlos Sampedrano C, Castaignet M, Lefebvre HP, Chetboul V. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases. J Vet Intern Med. 2008; 22: 905-914
DOI
ScienceOn
|
19 |
Rosenthal SL, Ferguson MJ, Lefbom BK. Association of pimobendan with ventricular arrhythmias in dogs with congestive heart failure, in Proceedings. Am Coll Vet Intern Med 2006; 110-115
|
20 |
Haggstrom J, Kvart C, Pedersen HD. Aquired valvular heart disease. In: Textbook of Veterinary Internal Medicine, 6 th ed. St Louis: Elsevier. 2005: 1022–1039
|
21 |
Lefbon BK. Sildenafil and novel cardiovascular therapies, in Proceedings. Am Coll Vet Intern Med 2005; 75-80.
|
22 |
Bonagura JD, Herring DS. Echocardiography; Acquired heart disease. Vet Clin North Am Small Anim Pract. 1985; 15: 1209-1224
PUBMED
|